ClinicalTrials.gg
Drug

Aficamten clinical trials

Also written CK-3773274.

studies test it
12
open now
2
in phase 3
7
first study started
2018

How each study uses aficamten is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the aficamten studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
19 Dec 2025 · MYQORZO · NDA 219083 (FDA, Drugs@FDA)
European Union
12 Feb 2026 · Myqorzo · EMEA/H/C/006228 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Aficamten
5

Development codes

CK-3773274
4
BAY3723113
1

Studies by the year they started

12 studies that test it; most in 2023 (4)

Studies that test aficamten, by start year
YearStudies
20181
20201
20212
20221
20234
20241
20251
20261

By phase

A phase 1/2 study counts in both.

Phase 1
3
Phase 2
3
Phase 3
7
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 1

Cytokinetics (8) · Corxel Pharmaceuticals (2) · Bayer (1) · Oregon Health and Science University (1)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 1

Studies that test aficamten.

Studies

Open first, then newest update. How each study uses aficamten is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 12

Codes

What other systems call aficamten · ClinicalTrials.gg INT002121

  • MeSH (NLM) C000731669aficamtenOne source NLM
  • UNII (FDA) B1I77MH6K1AFICAMTENConfirmed FDA, NLM, Wikidata
  • Wikidata Q106438207aficamtenConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C179072AficamtenOne source FDA
  • DrugBank DB18490One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.